Angiotensin Receptor Blockade
Showing 1 - 25 of >10,000
Therapeutic Drug Use for CKD Patients
Active, not recruiting
- Chronic Kidney Disease
- angiotensin converting enzyme inhibitors, angiotensin II receptor blockers, DPP-4 inhibitors, GLP-1 receptor agonists, SGLT2 inhibitors, calcium channel blockers, β Receptor blocker
-
Jinan, Shandong, ChinaXiao Li,MD
Apr 18, 2023
Renin Angiotensin Aldosterone System Genetic Polymorphism on
Recruiting
- Myocardial Infarction
-
Cairo, EgyptAin Shams University
May 16, 2023
Aortic Valve Stenosis Trial in Seoul (Angiotensin Receptor-Neprilysin Inhibitor, antihypertensive drugs including RAS inhibitors
Not yet recruiting
- Aortic Valve Stenosis
- Angiotensin Receptor-Neprilysin Inhibitor
- antihypertensive drugs including RAS inhibitors (ACE inhibitors or ARB)
-
Seoul, Korea, Republic ofAsan Medical Center
Jan 4, 2023
Coarctation of Aorta, High Blood Pressure Trial in Rochester (Losartan, Amlodipine, Placebo)
Not yet recruiting
- Coarctation of Aorta
- High Blood Pressure
- Losartan
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Nov 21, 2023
Novel Antidiabetic Drug Combined With Angiotensin
Recruiting
- Type 2 Diabetes
- Antidiabetic Drugs
-
Beijing, Beijing, China
- +1 more
Jun 20, 2023
Aortic Valve Stenosis, Valsartan, Angiotensin Receptor Antagonists Trial in Limoges (Valsartan, Placebo Oral Tablet)
Not yet recruiting
- Aortic Valve Stenosis
- +5 more
- Valsartan
- Placebo Oral Tablet
-
Limoges, FranceLimoges university hospital
Dec 23, 2022
Angiotensin Converting Enzyme Inhibitors and Angiotensin
Not yet recruiting
- COVID-19 Pneumonia
- Covid_19
- (no location specified)
Jun 5, 2022
Aortic Stenosis Trial in Québec, Odense (Angiotensin Receptor Blockers, Placebo)
Recruiting
- Aortic Stenosis
- Angiotensin Receptor Blockers
- Placebo
-
Québec, Quebec, Canada
- +1 more
Mar 28, 2022
Depressive Disorder, MDD, Bipolar Disorder Trial in West Haven (Perampanel 6 MG, Ketamine, Placebo)
Not yet recruiting
- Depressive Disorder
- +4 more
- Perampanel 6 MG
- +2 more
-
West Haven, ConnecticutVA Connecticut Healthcare System
Mar 14, 2023
Myocardial Infarction With Non-obstructive Coronary Arteries Trial in Worldwide (Beta blocker, ACEI, ARB)
Recruiting
- Myocardial Infarction With Non-obstructive Coronary Arteries
- Beta blocker
- +2 more
-
Adelaide, Sout Australi, Australia
- +19 more
Sep 6, 2021
Ehlers-Danlos Syndrome, Vascular Type Trial in France (Irbesartan, Placebo)
Completed
- Ehlers-Danlos Syndrome, Vascular Type
- Irbesartan
- Placebo
-
Bordeaux, France
- +14 more
Nov 2, 2020
Sleep Disordered Breathing, Hypoxia, Respiration; Sleep Disorder Trial in Kelowna (Hyperoxic Hypercapnic Ventilatory Response
Completed
- Sleep Disordered Breathing
- +3 more
- Hyperoxic Hypercapnic Ventilatory Response Test
- +5 more
-
Kelowna, British Columbia, CanadaUniversity of British Columbia
Sep 2, 2020
Systemic Right Ventricle, Heart Failure Trial in Montreal (Sacubitril / Valsartan Oral Tablet, Placebo)
Active, not recruiting
- Systemic Right Ventricle
- Heart Failure
- Sacubitril / Valsartan Oral Tablet
- Placebo
-
Montreal, Quebec, CanadaMontreal Heart Institute
Dec 21, 2022
Surgery, Angiotensin Hypertension, Perioperative Complication Trial in Netherlands (drug, diagnostic test, behavioral)
Recruiting
- Surgery
- +2 more
- Perioperative withdrawal of angiotensin converting enzyme inhibitors and angiotenin receptor blockers
- +4 more
-
Amsterdam, Netherlands
- +6 more
Jan 6, 2022
Kidney Disease Trial in United States (Bremelanotide, RAAS inhibition therapy)
Recruiting
- Kidney Disease
- Bremelanotide
- RAAS inhibition therapy
-
Chula Vista, California
- +5 more
Jan 23, 2023
The Effect of RAAS Blockers on ACE2 Levels
Completed
- Renin-Angiotensin System
- ACE inhibitor ,angiotensin receptor blockers
-
Cairo, Select A State Or Province, EgyptAinshams University
Jun 10, 2022
Chronic Kidney Allograft Nephropathy Trial in L'Hospitalet de Llobregat (Valsartan 80Mg Oral Tablet)
Recruiting
- Chronic Kidney Allograft Nephropathy
- Valsartan 80Mg Oral Tablet
-
L'Hospitalet de Llobregat, Barcelona, SpainNephrology Department. Hospital Universitari de Bellvitge
May 17, 2021
Acute Kidney Injury Trial (IRBESARTAN, tablet, 150 mg, Placebo, tablet, 150 mg)
Not yet recruiting
- Acute Kidney Injury
- IRBESARTAN, tablet, 150 mg
- Placebo, tablet, 150 mg
- (no location specified)
Aug 8, 2022
Anti-Angiotensin-Receptor 1-, Anti-Endothelin-Receptor
Completed
- Cardiac Failure
-
Wetzikon, SwitzerlandGZO Regional Health Center
Jul 13, 2021
COVID-19, SARS-CoV2 Infection Trial in India (Candesartan Cilexetil, Repagermanium, Candesartan Placebo)
Recruiting
- COVID-19
- SARS-CoV2 Infection
- Candesartan Cilexetil
- +3 more
-
Guntur, India
- +4 more
Mar 13, 2022
Cardiorenal Syndrome (CRS) Trial in Rochester (Candesartan, Placebo)
Completed
- Cardiorenal Syndrome (CRS)
- Candesartan
- Placebo
-
Rochester, MinnesotaMayo Clinic
Oct 20, 2021
Coronavirus Disease 2019, COVID-19 Trial in Australia, India (Angiotensin Receptor Blockers, Placebo)
Completed
- Coronavirus Disease 2019
- COVID-19
- Angiotensin Receptor Blockers
- Placebo
-
Camperdown, New South Wales, Australia
- +21 more
Mar 2, 2022
Heart Failure With Preserved Ejection Fraction Trial in Chongqing (Angiotensin Receptor-Neprilysin Inhibition, Placebo)
Not yet recruiting
- Heart Failure With Preserved Ejection Fraction
- Angiotensin Receptor-Neprilysin Inhibition
- Placebo
-
Chongqing, ChinaThe first affiliated Hospital of Chongqing Medical University
Oct 21, 2021
Chronic Kidney Disease, Blood Pressure, Angiotensin-converting Enzyme Inhibitor Trial in San Francisco (Continuation of ACEi
Active, not recruiting
- Chronic Kidney Disease
- +3 more
- Continuation of ACEi and/or ARBs
-
San Francisco, CaliforniaUniversity of California, San Francisco
Oct 4, 2021
MDD, Childhood Trauma Trial in Amsterdam (Mifepristone, Placebo)
Recruiting
- Major Depressive Disorder
- Childhood Trauma
- Mifepristone
- Placebo
-
Amsterdam, Noord-Holland, NetherlandsAmsterdam UMC, location VUmc
Mar 17, 2022